A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.
about
Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate CancerPotential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate CancerClinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancerEmerging PSA-based tests to improve screeningA prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessClinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literatureEnzymes and related proteins as cancer biomarkers: a proteomic approach.Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study.Biomarkers in prostate cancer surveillance and screening: past, present, and future.Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.Biomarkers in localized prostate cancer.The role of prostate cancer biomarkers in undiagnosed men.Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA rangeThe prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patients.Prostate cancer screening in Europe and Asia.
P2860
Q26767044-E08F5833-594C-404E-B9F6-130C9D10167DQ26784517-17A6240C-FB72-4A3D-91DF-B34EAAD4E974Q26824913-B61812F6-6614-4E67-AE98-FE32B02C68A8Q26828563-4C4B6348-CAEE-4969-92F1-2E32BBF8792DQ33839248-B7AF4B44-54B6-4BE0-BA3F-420224D8059FQ33911725-0BD2B9A7-C486-4709-A78C-296C446328EDQ33925261-1D1DCC26-253A-4C7B-934A-FF45B51268D4Q35838396-A065BAAE-1EBD-4635-A14E-02A4B47BC2E6Q36509148-D6F51D0D-3941-4761-907A-2010A7165B00Q37108081-B5971C87-2963-4823-991B-EC2E93AB8603Q37300931-891ADF2F-471F-4F45-A23D-3D47129F9C25Q37685652-6879FFD8-4B18-4867-AE91-77191B2AE0B4Q38697114-01DC4745-F926-4209-9BE8-668CBC8CEA4DQ39140686-7F529665-8DAB-480C-88B2-8FC24175F775Q40237929-E5D140CD-53FD-483C-B770-2F7D64C0BB45Q40438258-DAFD59A2-AD21-4287-AED8-F22C041674ECQ46569706-CAC6B77B-30D2-4AE8-9809-E677F2A6459CQ51771288-F2B6C0D9-8EAB-4554-957B-18F8A122CC0B
P2860
A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A precursor form of prostate-s ...... ansition zone prostate tissue.
@ast
A precursor form of prostate-s ...... ansition zone prostate tissue.
@en
type
label
A precursor form of prostate-s ...... ansition zone prostate tissue.
@ast
A precursor form of prostate-s ...... ansition zone prostate tissue.
@en
prefLabel
A precursor form of prostate-s ...... ansition zone prostate tissue.
@ast
A precursor form of prostate-s ...... ansition zone prostate tissue.
@en
P2093
P1433
P1476
A precursor form of prostate-s ...... ransition zone prostate tissue
@en
P2093
Mikolajczyk SD
Rittenhouse HG
Wheeler TM
P304
P407
P577
2000-02-01T00:00:00Z